Viracta Therapeutics, Inc. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Viracta Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Viracta Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -114 %, a 95.3% decline year-over-year.
  • Viracta Therapeutics, Inc. annual Return On Assets for 2023 was -71.5 %, a 32.8% decline from 2022.
  • Viracta Therapeutics, Inc. annual Return On Assets for 2022 was -53.8 %, a 42.6% increase from 2021.
  • Viracta Therapeutics, Inc. annual Return On Assets for 2021 was -93.7 %, a 64.2% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -71.5 -17.7 -32.8% Jan 1, 2023 Dec 31, 2023
2022 -53.8 +39.9 +42.6% Jan 1, 2022 Dec 31, 2022
2021 -93.7 -36.6 -64.2% Jan 1, 2021 Dec 31, 2021
2020 -57.1 -7.23 -14.5% Jan 1, 2020 Dec 31, 2020
2019 -49.8 +74.1 +59.8% Jan 1, 2019 Dec 31, 2019
2018 -124 +4.79 +3.72% Jan 1, 2018 Dec 31, 2018
2017 -129 -22.4 -21% Jan 1, 2017 Dec 31, 2017
2016 -106 -14.9 -16.2% Jan 1, 2016 Dec 31, 2016
2015 -91.5 -14 -18% Jan 1, 2015 Dec 31, 2015
2014 -77.5 -8.34 -12.1% Jan 1, 2014 Dec 31, 2014
2013 -69.2 +11 +13.7% Jan 1, 2013 Dec 31, 2013
2012 -80.2 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.